Dapagliflozin for metabolic dysfunction-associated steatohepatitis with fibrosis: a promising therapeutic agent in biopsy-diagnosed patients
Fields of Study & Subjects
Liver Disease Diagnosis and Treatment
Diabetes Treatment and Management
Drug-Induced Hepatotoxicity and Protection
Publication details
- Journal / source
- HepatoBiliary Surgery and Nutrition
- Volume
- 15
- Issue
- 2
- Pages
- 47–47
- Publication date
- 11 March 2026
- Language
- EN